{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:42:39Z","timestamp":1779183759462,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.clindermatol.2020.03.006","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T19:49:35Z","timestamp":1585079375000},"page":"462-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Emerging therapies in genodermatoses"],"prefix":"10.1016","volume":"38","author":[{"given":"Nanette","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.03.006_bb0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/jid.2011.453","article-title":"Identification of ectodysplasin target genes reveals the involvement of chemokines in hair development","volume":"132","author":"Lefebvre","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0020","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1124\/jpet.118.256040","article-title":"Prenatal treatment of X-linked hypohidrotic ectodermal dysplasia using recombinant ectodysplasin in a canine model","volume":"370","author":"Margolis","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0025","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJMoa1714322","article-title":"Prenatal correction of X-linked hypohidrotic ectodermal dysplasia","volume":"378","author":"Schneider","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0039-1691830","article-title":"Trametinib induces neurofibroma shrinkage and enables surgery","volume":"50","author":"Vaassen","year":"2019","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/pde.13995","article-title":"Autosomal recessive congenital ichthyosis due to homozygous variants in NIPAL4 with a dramatic response to ustekinumab","volume":"36","author":"Poulton","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0040","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bjd.15462","article-title":"Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14","volume":"178","author":"Lwin","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0045","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/annrheumdis-2017-211805","article-title":"High-dose ustekinumab for severe childhood deficiency of interleukin-36 receptor antagonist (DITRA)","volume":"77","author":"Bonekamp","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0050","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaad.2017.10.026","article-title":"The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: immunophenotyping and response to ustekinumab","volume":"78","author":"Paller","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0055","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jaci.2018.11.038","article-title":"BADBIR Study Group; BSTOP Study Group; PSORT Consortium. HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis","volume":"143","author":"Dand","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0060","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaci.2018.03.021","article-title":"Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature","volume":"143","author":"Malik","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2019.08.043","article-title":"Topical cholesterol\/lovastatin for the treatment of porokeratosis: a pathogenesis-directed therapy","volume":"82","author":"Atzmony","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1590\/abd1806-4841.20198789","article-title":"CHILD syndrome: successful treatment of skin lesions with topical lovastatin and cholesterol lotion","volume":"94","author":"Sandoval","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0075","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.jid.2019.07.723","article-title":"Second-hit somatic mutations in mevalonate pathway genes underlie porokeratosis","volume":"139","author":"Atzmony","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0080","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/pde.12587","article-title":"CHILD syndrome: successful treatment of skin lesions with topical simvastatin\/cholesterol ointment \u2013 a case report","volume":"32","author":"Alexopoulos","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0085","doi-asserted-by":"crossref","unstructured":"Maggio I, Zittersteijn HA, Wang Q, et al. Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components [e-pub ahead of print]. Gene Ther. https:\/\/doi.org\/10.1038\/s41434-019-0119-y, accessed March 1, 2020.","DOI":"10.1038\/s41434-019-0119-y"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0090","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1073\/pnas.1907081116","article-title":"CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells","volume":"116","author":"Jack\u00f3w","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2020.03.006_bb0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.clindermatol.2011.05.001","article-title":"Advances in dermatologic diagnosis, part II","volume":"29","author":"Wolf","year":"2011","journal-title":"Clin Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20300432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20300432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:54Z","timestamp":1760033814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20300432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0738081X20300432"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.03.006","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging therapies in genodermatoses","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}